Breast cancer Trials in Maplewood, United States
Conditions / Breast cancer / Maplewood, United States
Breast cancer has been the subject of sustained clinical investigation across multiple research sites.
52 total trials for this combination
Showing top 10 of 52 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07062965 | A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. | RECRUITING | — |
| NCT02032823 | Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT01598298 | S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy | COMPLETED | PHASE3 |
| NCT05879926 | Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 | RECRUITING | — |
| NCT00874211 | S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases | COMPLETED | — |
| NCT01674140 | S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05879926 | Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 | RECRUITING | — |
| NCT05896189 | Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors | RECRUITING | — |
| NCT05896189 | Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors | RECRUITING | — |
| NCT00625898 | BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab | TERMINATED | PHASE3 |